Fucosylated oligosaccharides have been proposed to be involved in multiple cell-cell interactions, including mouse blastocyst adhesion and intestine-microbe interactions. To begin to define the regulation and function of terminal ␣(1,2)fucosylated carbohydrates in these and other tissues, we isolated and characterized a 85-kilobase (kb) genomic region of mouse chromosome 7, 23.2 centimorgans analogous to human chromosome 19q13.3 that encodes three ␣(1,2)fucosyltransferases. Gene-specific DNA probes from the open reading frames of the mouse fucosyltransferase genes corresponding to human FUT1, FUT2, and SEC1 demonstrate distinct tissue-specific expression patterns by Northern blot analyses. Flow cytometry profiles of cultured cells transfected with DNA segments containing the open reading frames of the mouse genes confirm that each encodes an ␣(1,2)fucosyltransferase. In uterus and colon, a 3.3-kb FUT2 mRNA represents the major fucosyltransferase gene expressed. Steady-state FUT2 mRNA levels are cyclically regulated during the estrus cycle, increasing 10-fold from early diestrus to a relative maximum in proestrus. In contrast, SEC1 and FUT1 do not show prominently regulated expression in uterus. FUT2 expression localizes to luminal uterine epithelium by in situ hybridization, implying that this gene determines expression of cell surface Fuc␣132Gal epitopes proposed to mediate blastocyst adhesion.Implantation competence of uterine epithelium is hormonedependent (1) and is accompanied by morphological and biochemical changes in the luminal surface of this epithelium (2, 3). Although a variety of molecules have been implicated in the series of adhesive events leading to implantation, including fibronectin and laminin and their integrin counter-receptors (4 -11), cell surface heparin sulfate proteoglycans (12-16), and mucins (17), there is also compelling experimental evidence that specific cell surface glycoconjugates mediate the initial adhesive process (18 -22). Specifically, the terminal ␣(1,2)fucosylated oligosaccharide epitope known as the H type 1 moiety undergoes differential expression in the endometrium and early embryo, exhibits regulation during the mouse estrus cycle, and is present at a time appropriate for implantation (23)(24)(25). The epitope is also present on uterine epithelium of ovariectomized mice only after estrogen injection at a time correlated with endometrial receptivity (24). In addition, exogenous H type 1 oligosaccharide and monoclonal antibodies toward this epitope inhibit blastocyst adhesion in vitro, whereas isomeric oligosaccharides and isotype-controlled antibodies do not inhibit this attachment (25). Furthermore, a potential counter-receptor on hatched mouse blastocysts has been demonstrated by specific binding of fluorescently labeled H type 1 oligosaccharide (26,27). This binding was specific to the apical surface of mural trophectoderm where the initial adhesion to uterine epithelium is seen in the mouse. The glycosidic linkages of the H type 1 epitope, like other oligosacchari...